Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration

Completed

Conditions studied: Parkinson's Disease

In brief

The objective is to assess a compact, portable, wireless movement disorder system with continuous monitoring capabilities to detect and quantify the severity of levodopa-induced dyskinesia in Parkinson's disease.

Key facts

Study ID

NCT02125825

Run by

Great Lakes NeuroTechnologies Inc.

People needed

14

Starts

2014-07-01

Expected to finish

2014-12-01

Last updated by the study team

2016-01-12

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of idiopathic Parkinson's disease
• Clinical history of levodopa-induced dyskinesia
• 21 Years of age or older
• Stage 2 - 4 OFF-medication on the Hoehn and Yahr scale

You may not qualify if…

• Dementia (determined by a neuropsychological assessment)
• Severe tremor unaffected by levodopa

Where it is running

• Johns Hopkins Medical Center — Baltimore, Maryland, United States
• University of Rochester Medical Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.